MOLECULAR PARTNERS AG MOLN
ADS · ADR · CUSIP 60853G106
Biopharmaceutical company based in Zürich, Switzerland
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSchlieren, Switzerland
- Founded2004
- Websitemolecularpartners.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $20.47.
Biggest buyers
| MONTANOVA CAPITAL, LLC | New | +400.0k |
| Monashee Investment Management LLC | New | +250.0k |
| TUDOR INVESTMENT CORP ET AL | New | +175.0k |
| BlackRock Inc. | New | +165.0k |
| Hound Partners, LLC | New | +121.2k |
| Artal Group S.A. | New | +100.0k |
| Marshall Wace North America L.P. | New | +96.5k |
| MILLENNIUM MANAGEMENT LLC | New | +68.1k |
| CAAS CAPITAL MANAGEMENT LP | New | +60.0k |
| CAPSTONE INVESTMENT ADVISORS, LLC | New | +28.7k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC 13G · passive investor new · filed 2025-05-02 | 10.6% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME 13G · institution new · filed 2025-07-17 | 5.8% |
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2021.
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| MONTANOVA CAPITAL, LLC 0.12% of their portfolio | 400.0k $8.2m | New |
| Monashee Investment Management LLC 0.61% of their portfolio | 250.0k $5.1m | New |
| FEDERATED HERMES, INC. 0.01% of their portfolio | 235.3k $4.8m | Not comparable |
| TUDOR INVESTMENT CORP ET AL 0.07% of their portfolio | 175.0k $3.6m | New |
| BlackRock Inc. 0.00% of their portfolio | 165.0k $3.4m | New |
| Hound Partners, LLC 0.12% of their portfolio | 121.2k $2.5m | New |
| Artal Group S.A. 0.05% of their portfolio | 100.0k $2.0m | New |
| Marshall Wace North America L.P. 0.01% of their portfolio | 96.5k $2.0m | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 68.1k $1.4m | New |
| CAAS CAPITAL MANAGEMENT LP 0.07% of their portfolio | 60.0k $1.2m | New |
| CAPSTONE INVESTMENT ADVISORS, LLC 0.01% of their portfolio | 28.7k $589.0k | New |
| OLD MISSION CAPITAL LLC 0.01% of their portfolio | 14.8k $303.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 1.2k $25.0k | New |
| Westchester Capital Management, LLC 0.00% of their portfolio | 1.0k $20.0k | New |
| UBS Group AG 0.00% of their portfolio | 23 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |